FDA Approves Eli Lilly Alzheimer’s Drug

Share

The FDA has approved a new Alzheimer’s drug.  The new treatment by Eli Lilly will be sold under the brand name Kisunla, and was approved Tuesday by the FDA after outside experts said the benefits of the drug outweighed its risks.  The drug is designed to clear the brain of an Alzheimer’s-related protein called beta amyloid.  In a late-stage trial, the drug slowed the progression of memory problems by 29% compared with a placebo.  Lilly is charging about 700-dollars a vial for the drug, or 32-thousand dollars for a 12-month treatment.  

***Courtesy of Total Traffic News***

Spread the word

Trending Now

Featured News Podcasts

Subscribe to our Community Newsletter

By submitting this form, you are consenting to receive marketing emails from: Prairie Communications, 55 Public Square, Monmouth, IL, 61462, https://977wmoi.com/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Choose a Category

Continue Reading

Cultural Exploration Through Storytime

For families raising children in rural communities, opportunity often begins with access: access to education, to connection, and to the wider world beyond their community. With the goal of addressing

National Fentanyl Awareness Day

Today is National Fentanyl Awareness Day, first observed four years ago by parents who lost their loved ones to drug overdoses.  The goal is to remind people of the many

Cut Prescription Costs with New Savings Card

The pharmacy on the Solvera Health campus in Galesburg is now open to the community. With a commitment of bringing hospitality to healthcare, prescription drug savings cards are available, explains